Current Topics in Medicinal Chemistry


Jia Zhou
Chemical Biology Program
Department of Pharmacology and Toxicology
University of Texas Medical Branch
Galveston, TX

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Nitrogen-containing Heterocycle: A Privileged Scaffold for Marketed Drugs promotion: free to download

Volume:21   Issue: 6
Pp: 439-441
Feng Wang, Yongfang Yao, Hai-liang Zhu* and Yinghui Zhang*
DOI: 10.2174/156802662106210304105631
Published on: 08 April, 2021

An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors

Volume:21   Issue: 6
Pp: 442-460
Dima A. Sabbah*, Rima Hajjo, Sanaa K. Bardaweel and Haizhen A. Zhong
DOI: 10.2174/1568026620666201207095117
Published on: 08 April, 2021

Current Trends in Enzyme Inhibition and Docking Analysis in Drug Design-Part-IV free to download

Volume:21   Issue: 6
Pp: 461-461
Athina Geronikaki
DOI: 10.2174/156802662106210304111713
Published on: 08 April, 2021

Recent Advances in the Development of 1,2,3-Triazole-containing Derivatives as Potential Antifungal Agents and Inhibitors of Lanoster ol 14α-Demethylase

Volume:21   Issue: 6
Pp: 462-506
Michelyne Haroun*, Christophe Tratrat*, Hafedh Kochkar and Anroop B. Nair
DOI: 10.2174/1568026621999201214232018
Published on: 08 April, 2021

Docking Paradigm in Drug Design

Volume:21   Issue: 6
Pp: 507-546
Vladimir B. Sulimov*, Danil C. Kutov, Anna S. Taschilova, Ivan S. Ilin, Eugene E. Tyrtyshnikov and Alexey V. Sulimov
DOI: 10.2174/1568026620666201207095626
Published on: 08 April, 2021

Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host- Directed Therapies

Volume:21   Issue: 6
Pp: 547-570
Pobitra Borah, Pran K. Deb*, Katharigatta N. Venugopala, Nizar A. Al-Shar’i, Vinayak Singh, Satyendra Deka, Amavya Srivastava, Vinod Tiwari and Raghu P. Mailavaram
DOI: 10.2174/1568026621999201211200447
Published on: 08 April, 2021